Ali-Jackson Kamil sold RIGL
June 22, 2026 · Form 4 insider transaction
Ali-Jackson Kamil sold 2,500 shares of Rigel Pharmaceuticals, Inc. at $35.00 per share, a transaction worth $87.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,500
Price
$35.00
Total value
$87.5K
InsiderAli-Jackson Kamil
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 22, 2026
Filing dateJune 24, 2026
Shares owned after10,125
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.; The shares sold in this transaction were sold to cover applicable tax withholding obligations incurred upon the vesting of restricted stock units and were not sold for investment purposes.